Effect of prenatal antiarrhythmic treatment on cardiac function in a twin pregnancy

PACE - Pacing and Clinical Electrophysiology

Volumn 31, Issue 9, 2008, Pages 1213-1217

  Van Leeuwen, Peter ^a,c   Schiermeier, Sven ^a   Hailer, Birgit ^b   Lange, Silke ^a   Geue, Daniel ^a   Hatzmann, Wolfgang ^a   Grönemeyer, Dietrich ^a  

^a UNIVERSITY OF WITTEN HERDECKE   (Germany)

^b Philippusstift ^*  (Germany)

^c Gronemeyer Institute of Microtherapy   (Germany)

Author keywords

Cardiac time intervals; Fetal arrhythmia; Flecainide; Heart rate variability; Magnetocardiography

Indexed keywords

FLECAINIDE;

ADULT; ARTICLE; CASE REPORT; ECHOCARDIOGRAPHY; FEMALE; FETUS HEART RATE; HEART FUNCTION; HEART RATE VARIABILITY; HUMAN; MAGNETOCARDIOGRAPHY; QRS COMPLEX; SINUS RHYTHM; SUPRAVENTRICULAR TACHYCARDIA; TWIN PREGNANCY;

ADULT; ANTI-ARRHYTHMIA AGENTS; DISEASES IN TWINS; FEMALE; FETAL DISEASES; FLECAINIDE; HUMANS; PREGNANCY; PREGNANCY, MULTIPLE; PRENATAL CARE; TREATMENT OUTCOME; TWINS;

EID: 50449085565     PISSN: 01478389     EISSN: 15408159     Source Type: Journal    
DOI: 10.1111/j.1540-8159.2008.01165.x     Document Type: Article

References (22)

1. Naheed ZJ, Strasburger JF, Deal BJ, Benson DW Jr., Gidding SS. Fetal tachycardia: Mechanisms and predictors of hydrops fetalis. J Am Coll Cardiol 1996 27 : 1736 1740.
2. Simpson JM, Sharland GK. Fetal tachycardias: Management and outcome of 127 consecutive cases. Heart 1998 79 : 576 581.
3. Strasburger JF. Fetal arrhythmias. Prog Pediatr Cardiol 2000 11 : 1 17.
4. Oudijk MA, Ruskamp JM, Ambachtsheer BE, Ververs TF, Stoutenbeek P, Visser GH, Meijboom EJ. Drug treatment of fetal tachycardias. Paediatr Drugs 2002 4 : 49 63.
5. Echt DS, Liebson PR, Mitchell LB, Peters RW, Obias-Manno D, Barker AH, Arensberg D, et al. Mortality and morbidity in patients receiving encainide, flecainide, or placebo. The Cardiac Arrhythmia Suppression Trial. N Engl J Med 1991 324 : 781 788.
6. Krapp M, Baschat AA, Gembruch U, Geipel A, Germer U. Flecainide in the intrauterine treatment of fetal supraventricular tachycardia. Ultrasound Obstet Gynecol 2002 19 : 158 164.
7. Van Leeuwen P, Hailer B, Bader W, Geissler J, Trowitzsch E, Grönemeyer DH. Magnetocardiography in the diagnosis of fetal arrhythmia. Br J Obstet Gynaecol 1999 106 : 1200 1208.
8. Wakai RT, Leuthold AC, Cripe L, Martin CB. Assessment of fetal rhythm in complete congenital heart block by magnetocardiography. Pacing Clin Electrophysiol 2000 23 : 1047 1050.
9. Kähler C, Grimm B, Schleussner E, Schneider A, Schneider U, Nowak H, Vogt L, et al. The application of fetal magnetocardiography (FMCG) to investigate fetal arrhythmias and congenital heart defects (CHD). Prenat Diagn 2001 21 : 176 182.
10. Campbell JQ, Best TH, Eswaran H, Lowery CL. Fetal and maternal magnetocardiography during flecainide therapy for supraventricular tachycardia. Obstet Gynecol 2006 108 : 767 771.
11. Van Leeuwen P, Lange S, Klein A, Geue D, Zhang Y, Krause HJ, Grönemeyer D. Reproducibility and reliability of fetal cardiac time intervals using magnetocardiography. Physiol Meas 2004 25 : 539 552.
12. Lange S, Van Leeuwen P, Geue D, Hatzmann W, Grönemeyer D. Influence of gestational age, heart rate, gender and time of day on fetal heart rate variability. Med Biol Eng Comput 2005 43 : 481 486.
13. Van Leeuwen P, Lange S, Klein A, Geue D, Grönemeyer DHW. Dependency of magnetocardiographically determined fetal cardiac time intervals on gestational age, gender and postnatal biometrics in healthy pregnancies. BMC Pregnancy Childbirth 2004 4 : 6.
14. Task Force of the European Society of Cardiology and the North American Society of Pacing and Electrophysiology. Heart rate variability. Standards of measurement, physiological interpretation and clinical use. Circulation 1996 93 : 1043 1065.
15. Schiermeier S, van Leeuwen P, Lange S, Hatzmann W. Magnetocardiography - possibly a supplementary method for early detection of fetal distress in high-risk pregnancies. Z Geburtshilfe Neonatol 2005 209 : 38 41.
16. Schneider U, Fiedler A, Liehr M, Kahler C, Schleussner E. Fetal heart rate variability in growth restricted fetuses. Biomed Tech 2006 51 : 248 250.
17. Pincus SM, Viscarello RR. Approximate entropy: A regularity measure for fetal heart rate analysis. Obstet Gynecol 1992 79 : 249 255
18. Van Leeuwen P, Geue D, Lange S, Hatzmann W, Grönemeyer D. Changes in the frequency power spectrum of fetal heart rate in the course of pregnancy. Prenat Diag 2003 23 : 909 916.
19. Reddy UM, Ko CW, Willinger M. Maternal age and the risk of stillbirth throughout pregnancy in the United States. Am J Obstet Gynecol 2006 195 : 764 770.
20. Kahn B, Lumey LH, Zybert PA, Lorenz JM, Cleary-Goldman J, D'Alton ME, Robinson JN. Prospective risk of fetal death in singleton, twin, and triplet gestations: Implications for practice. Obstet Gynecol 2003 102 : 685 692.
21. Fauchier L, Babuty D, Autret ML, Poret P, Cosnay P, Fauchier JP. Effect of flecainide on heart rate variability in subjects without coronary artery disease or congestive heart failure. Cardiovasc Drugs Ther 1998 12 : 483 486.
22. van Gelder-Hasker MR, de Jong CL, de Vries JI, van Geijn HP. The effect of flecainide acetate on fetal heart rate variability: A case report. Obstet Gynecol 1995 86 : 667 669.